Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
|
NATUS MEDICAL INC (BABY)
|
Add to portfolio |
|
|
|
| Price: |
$24.00
| | Metrics |
| OS: |
34.6
|
M
| |
3
|
% ROE
|
| Market cap: |
$830
|
M
| |
12
|
% ROIC
|
|
Net cash:
|
$84.3
|
M
| |
$2.44
|
per share
|
|
EV:
|
$746
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$60.5
|
M
| |
12.3
|
x EV/EBITDA
|
|
EBIT
|
$33.0
|
M
| |
22.6
|
x EV/EBIT
|
| EPS |
$0.37
| |
64.2
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Jun-30-18 | Dec-31-17 | Jun-30-17 | Dec-31-16 |
| Revenues | 473.4 | 415.7 | 495.2 | 530.9 | 259.3 | 501.0 | 246.9 | 381.9 |
| Revenue growth | 13.9% | -16.1% | -6.7% | 6.0% | 5.0% | 31.2% | | 1.6% |
| Cost of goods sold | 6.7 | 13.2 | 6.9 | 8.9 | 108.3 | 219.8 | 111.5 | 147.0 |
| Gross profit | 466.7 | 402.4 | 488.3 | 522.0 | 151.0 | 281.2 | 135.4 | 234.9 |
| Gross margin | 98.6% | 96.8% | 98.6% | 98.3% | 58.2% | 56.1% | 54.8% | 61.5% |
| Sales and marketing | 116.0 | 107.3 | 129.1 | 136.7 | 69.3 | 126.2 | 62.6 | 84.8 |
| Research and development | 56.3 | 61.3 | 58.7 | 61.5 | 31.1 | 51.8 | 26.5 | 33.4 |
| General and administrative | 52.8 | 49.1 | 59.6 | 70.6 | 41.2 | 74.4 | 40.2 | 50.9 |
| EBITA | 48.6 | -1.2 | 44.2 | 35.3 | 9.5 | 28.8 | 6.2 | 65.8 |
| EBITA margin | 10.3% | -0.3% | 8.9% | 6.6% | 3.7% | 5.7% | 2.5% | 17.2% |
| Amortization of intangibles | 17.1 | 15.2 | 15.1 | 22.6 | 13.3 | 19.2 | 10.5 | 9.0 |
| EBIT | 31.5 | -16.4 | 29.1 | 12.7 | -3.8 | 9.6 | -4.3 | 56.8 |
| EBIT margin | 6.6% | -3.9% | 5.9% | 2.4% | -1.5% | 1.9% | -1.7% | 14.9% |
| Pre-tax income | 19.4 | -22.1 | -21.3 | -32.3 | -10.7 | 5.2 | -6.3 | 54.9 |
| Income taxes | 6.2 | -5.5 | -5.6 | -9.3 | -5.0 | 25.4 | -1.6 | 12.3 |
| Tax rate | 31.9% | 24.7% | 26.3% | 28.9% | 46.7% | 494.0% | 25.5% | 22.4% |
| Net income | 13.2 | -16.6 | -15.7 | -22.9 | -5.7 | -20.3 | -4.7 | 42.6 |
| Net margin | 2.8% | -4.0% | -3.2% | -4.3% | -2.2% | -4.1% | -1.9% | 11.2% |
| |
| Diluted EPS | $0.39 | ($0.49) | ($0.47) | ($0.69) | ($0.17) | ($0.62) | ($0.14) | $1.29 |
| Shares outstanding (diluted) | 34.0 | 33.6 | 33.7 | 33.1 | 32.8 | 32.6 | 32.5 | 33.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|